Pasithea Therapeutics Corp. Common Stock

KTTA

...

KTTA: Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

Show KTTA Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of KTTA by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by KTTA's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on KTTA's company Twitter account

WallStreetBets

Number of mentions of KTTA in WallStreetBets Daily Discussion

KTTA News

Recent insights relating to KTTA

CNBC Recommendations

Recent picks made for KTTA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KTTA

Corporate Flights

Flights by private jets registered to KTTA